Neoleukin Therapeutics Net Income 2013-2020 | NLTX

Neoleukin Therapeutics net income from 2013 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Neoleukin Therapeutics Annual Net Income
(Millions of US $)
2020 $-33
2019 $-69
2018 $-32
2017 $-50
2016 $-37
2015 $-22
2014 $-24
2013 $-15
2012 $-12
Neoleukin Therapeutics Quarterly Net Income
(Millions of US $)
2020-12-31
2020-09-30 $-2
2020-06-30 $-10
2020-03-31 $-9
2019-12-31 $-8
2019-09-30 $-59
2019-06-30 $-0
2019-03-31 $-2
2018-12-31 $-5
2018-09-30 $-15
2018-06-30 $3
2018-03-31 $-15
2017-12-31 $-16
2017-09-30 $-12
2017-06-30 $-14
2017-03-31 $-8
2016-12-31 $-11
2016-09-30 $-8
2016-06-30 $-11
2016-03-31 $-7
2015-12-31 $-6
2015-09-30 $-5
2015-06-30 $-5
2015-03-31 $-6
2014-12-31 $-8
2014-09-30 $-6
2014-06-30 $-5
2014-03-31 $-4
2013-12-31 $-4
2013-09-30 $-5
2013-06-30 $-2
2013-03-31 $-3
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.506B $0.025B
Neoleukin Therapeutics Inc. is a biopharmaceutical company. It is engaged in creating next generation immunotherapies using de novo protein design technology. The company's product candidate consists of NL-201 which is in clinical stage. Neoleukin Therapeutics Inc., formerly known as Aquinox Pharmaceuticals Inc., is based in Seattle, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $147.238B 15.40
Bristol Myers Squibb (BMY) United States $146.233B 10.16
CSL (CSLLY) Australia $95.302B 0.00
Gilead Sciences (GILD) United States $84.193B 9.43
Moderna (MRNA) United States $68.414B 0.00
Illumina (ILMN) United States $58.214B 88.67
Vertex Pharmaceuticals (VRTX) United States $56.783B 24.24
Regeneron Pharmaceuticals (REGN) United States $53.845B 17.60
Biogen (BIIB) United States $41.178B 8.24
BioNTech SE (BNTX) Germany $36.600B 947.13
Alexion Pharmaceuticals (ALXN) United States $36.159B 14.01
BeiGene (BGNE) Cayman Islands $28.018B 0.00
Seagen (SGEN) United States $26.380B 45.19
Genmab (GMAB) Denmark $23.106B 32.32
Exact Sciences (EXAS) United States $21.989B 0.00
Genmab (GNMSF) Denmark $21.839B 5.18
Horizon Therapeutics Public (HZNP) Ireland $20.899B 23.98
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Incyte (INCY) United States $18.177B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.932B 57.06
Novavax (NVAX) United States $16.792B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.293B 0.00
Bio-Techne Corp (TECH) United States $16.239B 93.01
Guardant Health (GH) United States $15.918B 0.00
Zai Lab (ZLAB) China $14.555B 0.00
ARGENX SE-ADR (ARGX) Netherlands $14.454B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.437B 115.07
QIAGEN (QGEN) Netherlands $12.026B 24.53
Repligen (RGEN) United States $11.683B 128.49
CRISPR Therapeutics AG (CRSP) Switzerland $8.943B 0.00
AbCellera Biologics (ABCL) $8.036B 0.00
Mirati Therapeutics (MRTX) United States $8.010B 0.00
Fate Therapeutics (FATE) United States $7.612B 0.00
Acceleron Pharma (XLRN) United States $7.390B 0.00
Exelixis (EXEL) United States $7.360B 67.40
Ultragenyx Pharmaceutical (RARE) United States $7.279B 0.00
Halozyme Therapeutics (HALO) United States $6.651B 51.57
Twist Bioscience (TWST) United States $6.579B 0.00
Ascendis Pharma (ASND) Denmark $6.555B 0.00
Denali Therapeutics (DNLI) United States $6.534B 207.73
Vir Biotechnology (VIR) United States $5.936B 0.00
Adaptive Biotechnologies (ADPT) United States $5.851B 0.00
NeoGenomics (NEO) United States $5.775B 704.86
Sarepta Therapeutics (SRPT) United States $5.702B 0.00
Blueprint Medicines (BPMC) United States $5.518B 18.17
Galapagos (GLPG) Belgium $5.185B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.040B 15.85
Intellia Therapeutics (NTLA) United States $4.771B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $4.616B 0.00
Beam Therapeutics (BEAM) United States $4.541B 0.00
Certara (CERT) United States $4.293B 0.00
Emergent Biosolutions (EBS) United States $4.160B 9.89
I-Mab (IMAB) China $4.101B 0.00
Arena Pharmaceuticals (ARNA) United States $3.976B 0.00
Atea Pharmaceuticals (AVIR) United States $3.718B 0.00
Apellis Pharmaceuticals (APLS) United States $3.663B 0.00
Legend Biotech (LEGN) United States $3.458B 0.00
SpringWorks Therapeutics (SWTX) United States $3.429B 0.00
Insmed (INSM) United States $3.415B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.385B 0.00
Reata Pharmaceuticals (RETA) United States $3.290B 0.00
Berkeley Lights (BLI) United States $3.177B 0.00
Alkermes (ALKS) Ireland $3.164B 0.00
Arvinas (ARVN) United States $3.162B 0.00
Seer (SEER) $3.097B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.022B 42.81
MorphoSys AG (MOR) Germany $2.980B 45.30
Deciphera Pharmaceuticals (DCPH) United States $2.708B 0.00
Vericel (VCEL) United States $2.702B 1172.40
Amicus Therapeutics (FOLD) United States $2.627B 0.00
Global Blood Therapeutics (GBT) United States $2.537B 0.00
Intra-Cellular Therapies (ITCI) United States $2.526B 0.00
Ligand Pharmaceuticals (LGND) United States $2.496B 47.24
ALX Oncology Holdings (ALXO) United States $2.437B 0.00
Arcus Biosciences (RCUS) United States $2.348B 0.00
Editas Medicine (EDIT) United States $2.335B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.210B 0.00
Sorrento Therapeutics (SRNE) United States $2.140B 0.00
PHARMA MAR SA (PHMMF) Spain $2.074B 0.00
Myriad Genetics (MYGN) United States $2.054B 0.00
NGM Biopharmaceuticals (NGM) United States $2.006B 0.00
Amarin (AMRN) Ireland $1.975B 0.00
Revance Therapeutics (RVNC) United States $1.943B 0.00
Bluebird Bio (BLUE) United States $1.899B 0.00
Seres Therapeutics (MCRB) United States $1.898B 0.00
Heska (HSKA) United States $1.870B 0.00
Inovio Pharmaceuticals (INO) United States $1.821B 0.00
Morphic Holding (MORF) United States $1.787B 0.00
Five Prime Therapeutics (FPRX) United States $1.770B 0.00
Cytokinetics (CYTK) United States $1.767B 0.00
Genetron Holdings (GTH) China $1.763B 0.00
Kymera Therapeutics (KYMR) United States $1.732B 0.00
PureTech Health (PRTC) United States $1.653B 0.00
Sangamo Therapeutics (SGMO) United States $1.650B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.650B 0.00
Castle Biosciences (CSTL) United States $1.636B 0.00
BioAtla (BCAB) United States $1.607B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.604B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.602B 0.00
Bionano Genomics (BNGO) United States $1.577B 0.00
Precigen (PGEN) United States $1.540B 0.00
UniQure (QURE) Netherlands $1.533B 0.00
Codexis (CDXS) United States $1.520B 0.00
Travere Therapeutics (TVTX) United States $1.508B 0.00
REGENXBIO (RGNX) United States $1.467B 0.00
Cara Therapeutics (CARA) United States $1.422B 356.38
Alector (ALEC) United States $1.417B 0.00
Zealand Pharma (ZEAL) Denmark $1.413B 0.00
C4 Therapeutics (CCCC) United States $1.404B 0.00
Zymeworks (ZYME) Canada $1.402B 0.00
Keros Therapeutics (KROS) United States $1.319B 0.00
MiMedx (MDXG) United States $1.297B 0.00
Nurix Therapeutics (NRIX) United States $1.287B 0.00
Shattuck Labs (STTK) United States $1.254B 0.00
Repare Therapeutics (RPTX) Canada $1.246B 0.00
Dynavax Technologies (DVAX) United States $1.245B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.215B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Protagonist Therapeutics (PTGX) United States $1.167B 0.00
Avid Bioservices (CDMO) United States $1.165B 0.00
Mesoblast (MESO) Australia $1.160B 0.00
Mersana Therapeutics (MRSN) United States $1.150B 0.00
Nkarta (NKTX) United States $1.143B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.141B 0.00
Northwest Biotherapeutics (NWBO) United States $1.130B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.123B 0.00
Ocugen (OCGN) United States $1.087B 0.00
Pliant Therapeutics (PLRX) United States $1.070B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.060B 0.00
Scholar Rock Holding (SRRK) United States $1.054B 0.00
Coherus BioSciences (CHRS) United States $1.052B 8.51
Curis (CRIS) United States $1.052B 0.00
MannKind (MNKD) United States $1.041B 0.00
Prothena (PRTA) Ireland $0.994B 0.00
G1 THERAPEUTICS (GTHX) United States $0.986B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.985B 0.00
Prometheus Biosciences (RXDX) United States $0.968B 0.00
Celldex Therapeutics (CLDX) United States $0.933B 0.00
Sutro Biopharma (STRO) United States $0.918B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.915B 38.77
Adverum Biotechnologies (ADVM) United States $0.866B 0.00
Merus (MRUS) Netherlands $0.859B 0.00
Affimed (AFMD) Germany $0.840B 0.00
Pharming Group (PHAR) Netherlands $0.835B 0.00
Cellectis S.A (CLLS) France $0.830B 0.00
Epizyme (EPZM) United States $0.824B 0.00
Bolt Biotherapeutics (BOLT) United States $0.812B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.788B 0.00
Pharming Group (PHGUF) Netherlands $0.782B 20.83
Avidity Biosciences (RNA) United States $0.780B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.766B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.745B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.729B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.717B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.703B 0.00
VBI Vaccines (VBIV) United States $0.688B 0.00
Inhibrx (INBX) United States $0.681B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.680B 0.00
Kadmon Holdings (KDMN) United States $0.674B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.670B 0.00
DBV Technologies S.A (DBVT) France $0.664B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Clovis Oncology (CLVS) United States $0.625B 0.00
MeiraGTx Holdings (MGTX) United States $0.623B 0.00
ALBIREO PHARMA (ALBO) United States $0.623B 0.00
Starpharma Holdings (SPHRY) Australia $0.601B 0.00
IDEAYA Biosciences (IDYA) United States $0.600B 0.00
AnaptysBio (ANAB) United States $0.594B 0.00
Compugen (CGEN) Israel $0.586B 0.00
Adagene (ADAG) $0.580B 0.00
Anika Therapeutics (ANIK) United States $0.576B 191.48
ChromaDex (CDXC) United States $0.547B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.539B 0.00
Agenus (AGEN) United States $0.536B 0.00
RAPT THERAPTICS (RAPT) United States $0.519B 0.00
Inventiva S.A (IVA) France $0.515B 0.00
Precision BioSciences (DTIL) United States $0.501B 0.00
Forte Biosciences (FBRX) United States $0.497B 0.00
XBiotech (XBIT) United States $0.495B 0.00
Amryt Pharma (AMYT) United Kingdom $0.493B 0.00
CytomX Therapeutics (CTMX) United States $0.487B 0.00
AC Immune SA (ACIU) Switzerland $0.484B 0.00
Geron (GERN) United States $0.468B 0.00
Verastem (VSTM) United States $0.460B 0.00
Kala Pharmaceuticals (KALA) United States $0.460B 0.00
Selecta Biosciences (SELB) United States $0.435B 0.00
Gritstone Oncology (GRTS) United States $0.423B 0.00
ANI Pharmaceuticals (ANIP) United States $0.423B 11.79
XOMA (XOMA) United States $0.422B 93.75
AquaBounty Technologies (AQB) United States $0.415B 0.00
Angion Biomedica (ANGN) United States $0.415B 0.00
Seelos Therapeutics (SEEL) United States $0.412B 0.00
Puma Biotechnology (PBYI) United States $0.405B 0.00
Opthea (OPT) Australia $0.395B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.392B 0.00
Cue Biopharma (CUE) United States $0.391B 0.00
Fortress Biotech (FBIO) United States $0.391B 0.00
SESEN BIO, INC (SESN) United States $0.390B 0.00
Adicet Bio (ACET) United States $0.389B 0.00
UROGEN PHARMA (URGN) United States $0.383B 0.00
Syros Pharmaceuticals (SYRS) United States $0.383B 0.00
Spero Therapeutics (SPRO) United States $0.381B 0.00
Fulcrum Therapeutics (FULC) United States $0.377B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.376B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.375B 0.00
Athenex (ATNX) United States $0.371B 0.00
Athersys (ATHX) United States $0.364B 0.00
Bellus Health (BLU) Canada $0.359B 0.00
SQZ Biotechnologies (SQZ) United States $0.354B 0.00
Innate Pharma S.A (IPHA) France $0.348B 0.00
BioDelivery Sciences (BDSI) United States $0.345B 13.68
Theratechnologies (THTX) Canada $0.338B 0.00
Frequency Therapeutics (FREQ) United States $0.328B 0.00
HOOKIPA Pharma (HOOK) United States $0.326B 0.00
Cogent Biosciences (COGT) United States $0.316B 0.00
Oncobiologics (OTLK) United States $0.316B 0.00
Cardiff Oncology (CRDF) United States $0.311B 0.00
WAVE Life Sciences (WVE) Singapore $0.307B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.301B 0.00
Trevena (TRVN) United States $0.300B 0.00
CorMedix Inc (CRMD) United States $0.297B 0.00
Arbutus Biopharma (ABUS) United States $0.296B 0.00
Codiak BioSciences (CDAK) United States $0.283B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.277B 0.00
Kaleido Biosciences (KLDO) $0.276B 0.00
Kamada (KMDA) Israel $0.275B 15.82
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.269B 0.00
NextCure (NXTC) United States $0.260B 0.00
OVID THERAPEUTC (OVID) United States $0.249B 0.00
Cerecor (CERC) United States $0.224B 0.00
VTv Therapeutics (VTVT) United States $0.219B 0.00
Checkpoint Therapeutics (CKPT) United States $0.214B 0.00
Prima BioMed (IMMP) Australia $0.213B 0.00
OSMOTICA PHARM (OSMT) United States $0.205B 0.00
INmune Bio (INMB) United States $0.203B 0.00
Kindred Biosciences (KIN) United States $0.201B 0.00
ADMA Biologics Inc (ADMA) United States $0.200B 0.00
Eton Pharmaceuticals (ETON) United States $0.197B 0.00
TELA Bio (TELA) United States $0.196B 0.00
POXEL SA FRANCE (PXXLF) France $0.193B 0.00
LogicBio Therapeutics (LOGC) United States $0.188B 0.00
GENFIT S.A (GNFT) France $0.181B 0.00
Aptinyx (APTX) United States $0.179B 0.00
DiaMedica Therapeutics (DMAC) United States $0.178B 0.00
Nicox SA (NICXF) France $0.172B 0.00
Voyager Therapeutics (VYGR) United States $0.172B 4.80
Applied Genetic Technologies (AGTC) United States $0.171B 0.00
Chiasma (CHMA) United States $0.169B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.168B 0.00
Strongbridge Biopharma (SBBP) United States $0.164B 0.00
Antibe Therapeutics (ATBPF) Canada $0.163B 0.00
ObsEva SA (OBSV) Switzerland $0.162B 0.00
Enzo Biochem (ENZ) United States $0.161B 0.00
Clearside Biomedical (CLSD) United States $0.158B 0.00
Exicure (XCUR) United States $0.158B 0.00
X4 Pharmaceuticals (XFOR) United States $0.157B 0.00
Biofrontera AG (BFRA) Germany $0.152B 0.00
Catalyst Biosciences (CBIO) United States $0.149B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.148B 0.00
Abeona Therapeutics (ABEO) United States $0.148B 0.00
Erytech Pharma SA (ERYP) France $0.146B 0.00
Dyadic (DYAI) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.138B 0.00
Synlogic (SYBX) United States $0.135B 0.00
Evofem Biosciences (EVFM) United States $0.130B 0.00
Eyenovia (EYEN) United States $0.129B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.127B 0.00
Orgenesis (ORGS) United States $0.125B 257.00
TRACON Pharmaceuticals (TCON) United States $0.125B 0.00
Liminal BioSciences (LMNL) Canada $0.124B 0.00
Liquidia Technologies (LQDA) United States $0.120B 0.00
Aytu BioPharma (AYTU) United States $0.116B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.114B 0.00
Galena Biopharma (SLS) United States $0.114B 0.00
Aptevo Therapeutics (APVO) United States $0.113B 0.00
Evogene (EVGN) Israel $0.113B 0.00
Beyond Air (XAIR) United States $0.112B 0.00
Zosano Pharma (ZSAN) United States $0.108B 0.00
Ecology Coatings (ABVC) United States $0.107B 0.00
Novogen (KZIA) Australia $0.107B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
ARAVIVE, INC (ARAV) United States $0.102B 0.00
Lumos Pharma (LUMO) United States $0.101B 0.00
Leap Therapeutics (LPTX) United States $0.098B 0.00
Celyad SA (CYAD) Belgium $0.097B 0.00
PHASEBIO PHARMA (PHAS) United States $0.094B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.092B 0.00
Cyclerion Therapeutics (CYCN) United States $0.088B 0.00
Cocrystal Pharma (COCP) United States $0.086B 0.00
Cleveland BioLabs (CBLI) United States $0.082B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.082B 0.00
Vascular Biogenics (VBLT) Israel $0.081B 0.00
Celsion (CLSN) United States $0.080B 0.00
AIkido Pharma (AIKI) United States $0.079B 0.00
CytRx (CYTR) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
Vaccinex (VCNX) United States $0.069B 0.00
Edesa Biotech (EDSA) Canada $0.068B 0.00
Purple Biotech (PPBT) Israel $0.068B 0.00
BioCardia (BCDA) United States $0.065B 0.00
Emmaus Life Sciences (EMMA) United States $0.064B 0.00
ARIDIS PHARMACT (ARDS) United States $0.063B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.062B 0.00
ATyr Pharma (LIFE) United States $0.060B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Genetic Technologies (GENE) Australia $0.058B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
Advaxis (ADXS) United States $0.056B 0.00
Alimera Sciences (ALIM) United States $0.056B 0.00
Windtree Therapeutics (WINT) United States $0.056B 0.00
AnPac Bio-Medical Science (ANPC) China $0.056B 0.00
AEterna Zentaris (AEZS) United States $0.055B 0.00
Pulmatrix (PULM) United States $0.055B 0.00
Appili Therapeutics (APLIF) Canada $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Enveric Biosciences (ENVB) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.046B 0.00
Yumanity Therapeutics (YMTX) United States $0.046B 0.00
Cyclo Therapeutics (CYTH) United States $0.044B 0.00
Clene (CLNN) United States $0.040B 0.00
Vyant Bio (VYNT) United States $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.040B 0.59
Invo BioScience (INVO) United States $0.039B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.037B 0.00
Vallon Pharmaceuticals (VLON) United States $0.031B 0.00
IMMURON (IMRN) Australia $0.031B 0.00
GeoVax Labs (GOVX) United States $0.030B 0.00
ThermoGenesis Holdings (THMO) United States $0.029B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.025B 0.00
Seneca Biopharma (SNCA) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Benitec Biopharma (BNTC) United States $0.022B 0.00
China Biologic Products (CBPO) China $0.000B 29.28
Entera Bio (ENTX) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00